Apr 01, 2020
AMCP Files Amicus Brief with U.S. Supreme Court Case on Rutledge v. PCMA
Mar 10, 2020
PBMs Affirm Readiness to Assist Patients with COVID-19
Mar 05, 2020
New Academic Analysis Sets the Record Straight: Number of Independent Pharmacies in U.S. Increasing
Sep 13, 2019
HHS Office of Inspector General Report Shows Rebates Reduced Medicare Part D Drug Spending
Jun 19, 2019
PBMs Advocate on behalf of Consumers to Reduce Prescription Drug Costs
May 02, 2019
New CBO Analysis of Administration's Proposed Rebate Rule Confirms Higher Premiums and Federal Spending
Apr 10, 2019
PCMA: Greater Competition on Insulin Products Key to Reducing Prices
Apr 09, 2019
PBMs Advocate for Consumers and Health Plans to Reduce Prescription Drug Costs
Apr 08, 2019
PCMA Submits Comments on the Administration's Proposed Rule Revising the Safe Harbors for Prescription Drug Rebates
Apr 04, 2019
PCMA New Analysis: HHS Proposed Rebate Rule 'Poorly Conceived'
Mar 11, 2019
PCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers in Texas
Mar 07, 2019
PCMA Statement on Congressional Committee Hearings on Drug Prices
Mar 06, 2019
PCMA Statement on Prescription Drug Rebate Legislation
Mar 05, 2019
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs for New Yorkers
Feb 28, 2019
PCMA Statement on Pennsylvania Auditor General Drug Pricing Report
Feb 25, 2019
PCMA Statement on Senate Finance Committee Hearing on Drug Prices
Jan 31, 2019
PCMA Statement on the Administration's Prescription Drug Rebate Proposed Rule
Jan 28, 2019
PCMA Offers Policy Solutions to Reduce Prescription Drug Costs
Jan 02, 2019
PCMA Welcomes New Appointments, Announces New Roles
Dec 20, 2018
PCMA: Drug Manufacturer Price Hikes Offset by Rebates